What happens
The Food and Drug Administration has approved a second booster dose of the Pfizer and Moderna COVID-19 vaccines for people over the age of 50 or with a weakened immune system. The announcement, made late last month, came amid concerns that an even more contagious version of the Omicron variant – known as BA.2 – could lead to an increase in cases in the US, as it did in Europe and parts of the world. Asian in recent weeks. The second booster is the fourth vaccine for people who were originally vaccinated with the Pfizer or Moderna mRNA vaccine or the third dose for those who started the Johnson & Johnson vaccine. Despite the Biden administration’s aggressive campaign to promote reinforcements and strong evidence that they provide a significant increase in protection, the initial booster dose has been delayed in the US. Only about 45 percent of fully vaccinated Americans have received their first booster, according to Centers for Disease Control and Prevention. Just under a quarter of the US population has not been vaccinated at all. At this stage of the pandemic, there is a huge body of data that vaccines dramatically reduce the risk of serious COVID infections and death, and an initial booster dose further enhances this protection. The evidence supporting the use of a second amplifier is much more limited. An Israeli study found that a fourth shot reduced the risk of death in people over the age of 60, but there are questions about how long this extra protection lasts and how much the second boosters help younger groups.
Why is there a discussion
This lack of clear data has led to disagreement among health experts as to whether the FDA made the right decision by approving second boost shots for older Americans. Proponents of her case have been working to make the actual transcript of this statement available online. Proponents of her case have been working to make the actual transcript of this statement available online. Others argue that it is prudent to make a mistake with caution, given the unpredictable nature of the pandemic and the large variation in the level of risk that individual Americans face from the virus. The story goes on Critics of the decision say that while the fourth dose is as safe as the first, there are some risks involved in promoting the second amplifier. They argue that the extra protection provided by another amplifier is minimal and could disappear in a few weeks. There are also concerns about “vaccine fatigue”, which could arise if health officials continue to ask people to return for more doses without strong indications that they make a significant difference.
What’s next
Looking to break the cycle of periodic increases each time a new variant occurs, scientists are working to develop a universal coronavirus vaccine that could protect against all forms of the virus and possibly provide more lasting immunity. Although it is possible in theory, such a discovery is still considered a holy grail by researchers that could take years to become a reality.
Perspectives
Supporters
It’s okay there is no clear answer right now “I do not think it is a right or wrong answer with clear overwhelming evidence in one way or another. That may make it a little confusing for everyone. ” – Alessandro Sette, immunologist, at Vox Vulnerable Americans are at greater risk every day as their protection diminishes “Too many people have reduced antibodies and there is still the benefit of being protected from this new wave that may or may not come.” – Katelyn Jetelina, epidemiologist, at Yahoo News There is virtually no risk of taking an extra dose “The positive effects of a fourth shot are indeed uncertain: The best we can say at the moment is that its protective effects are probably moderate and temporary (with greater benefits for the elderly). “But a modest, temporary boost is still better than nothing – so why not go ahead and get one, just in case?” – Rachel Gattman, The Atlantic The pandemic has shown that it is always better to have more protection “While it is clear that the FDA is careful, I like their decision. Let ‘s face it: Every time we thought the shore was clear to Covid, we were wrong. “And every time we thought we had collective immunity to the virus – from a previous illness or from vaccines – we were wrong.” – Kent Sepkowitz, CNN The FDA was smart to make the second amplifiers a matter of personal choice “Those who have been vaccinated and strengthened may not choose an extra souvenir at this time, as they could choose not to wear a mask or have regular tests. … For the elderly and the medically weak who would end up in the hospital with any respiratory infection, I understand the rationale for choosing the extra shot. “They want to do everything they can to avoid infection with Covid-19.” – Leana Wen, Washington Post
Skeptics
We need better vaccines, not more doses than we already have “It has become clear that our current vaccines will not end the pandemic. But that’s no reason to give up hope. a vaccination campaign with better vaccines could still. ” – Fay Flam, Bloomberg The second amplifiers seem to make only a small difference “A fourth dose of mRNA vaccine for the average, healthy American can reduce the incidence of mild infections for weeks to months, but would have little additional impact on preventing serious illness and death.” – John P. Moore and Luciana L. Borio, Stat The goal should be to prevent serious infections and deaths, the initial doses already do “Protection against vaccine-induced infection is short-lived and is not greatly enhanced by additional vaccines. However, the initial two-dose regimen is sufficient to provide most patients with excellent protection against serious disease. – Philip Krause and Luciana Borio, Wall Street Journal It does not make sense to give people support when the incidence is relatively low “COVID vaccines are safe and effective and have undoubtedly saved millions of lives so far. “I think amplifiers are important and will continue to help save lives – but timing matters.” – Eddy Bresnitz, Philadelphia Inquirer The talk of souvenirs is irrelevant to so many people still unvaccinated “The most important thing we can do as individuals right now is, No. 1, to vaccinate the unvaccinated. There are so many people who have not started their turn for any reason. … The solution to this pandemic is to vaccinate as many people as possible. It’s still the solution to take us to the other side. ” – Sabrina Assoumou, infectious disease specialist, at the Boston Globe Vaccine fatigue is a real concern “What is the risk of frequent aid? There do not appear to be any immunological risks / health risks and opportunity costs. But there are psychological risks (eg vaccine fatigue & skepticism). “We have to ask the Americans to roll up their sleeves when it matters most.” – Céline Gounder, epidemiologist Is there an issue you would like to see covered in “The 360”? Send your suggestions to [email protected] Photo Illustration: Yahoo News? photos: Justin Sullivan / Getty Images
title: “The Debate Over 2Nd Covid Boosters " ShowToc: true date: “2022-11-06” author: “Danny Perez”
What happens
The Food and Drug Administration has approved a second booster dose of the Pfizer and Moderna COVID-19 vaccines for people over the age of 50 or with a weakened immune system. The announcement, made late last month, came amid concerns that an even more contagious version of the Omicron variant – known as BA.2 – could lead to an increase in cases in the US, as it did in Europe and parts of the world. Asian in recent weeks. The second booster is the fourth vaccine for people who were originally vaccinated with the Pfizer or Moderna mRNA vaccine or the third dose for those who started the Johnson & Johnson vaccine. Despite the Biden administration’s aggressive campaign to promote reinforcements and strong evidence that they provide a significant increase in protection, the initial booster dose has been delayed in the US. Only about 45 percent of fully vaccinated Americans have received their first booster, according to Centers for Disease Control and Prevention. Just under a quarter of the US population has not been vaccinated at all. At this stage of the pandemic, there is a huge body of data that vaccines dramatically reduce the risk of serious COVID infections and death, and an initial booster dose further enhances this protection. The evidence supporting the use of a second amplifier is much more limited. An Israeli study found that a fourth shot reduced the risk of death in people over the age of 60, but there are questions about how long this extra protection lasts and how much the second boosters help younger groups.
Why is there a discussion
This lack of clear data has led to disagreement among health experts as to whether the FDA made the right decision by approving second boost shots for older Americans. Proponents of her case have been working to make the actual transcript of this statement available online. Proponents of her case have been working to make the actual transcript of this statement available online. Others argue that it is prudent to make a mistake with caution, given the unpredictable nature of the pandemic and the large variation in the level of risk that individual Americans face from the virus. The story goes on Critics of the decision say that while the fourth dose is as safe as the first, there are some risks involved in promoting the second amplifier. They argue that the extra protection provided by another amplifier is minimal and could disappear in a few weeks. There are also concerns about “vaccine fatigue”, which could arise if health officials continue to ask people to return for more doses without strong indications that they make a significant difference.
What’s next
Looking to break the cycle of periodic increases each time a new variant occurs, scientists are working to develop a universal coronavirus vaccine that could protect against all forms of the virus and possibly provide more lasting immunity. Although it is possible in theory, such a discovery is still considered a holy grail by researchers that could take years to become a reality.
Perspectives
Supporters
It’s okay there is no clear answer right now “I do not think it is a right or wrong answer with clear overwhelming evidence in one way or another. That may make it a little confusing for everyone. ” – Alessandro Sette, immunologist, at Vox Vulnerable Americans are at greater risk every day as their protection diminishes “Too many people have reduced antibodies and there is still the benefit of being protected from this new wave that may or may not come.” – Katelyn Jetelina, epidemiologist, at Yahoo News There is virtually no risk of taking an extra dose “The positive effects of a fourth shot are indeed uncertain: The best we can say at the moment is that its protective effects are probably moderate and temporary (with greater benefits for the elderly). “But a modest, temporary boost is still better than nothing – so why not go ahead and get one, just in case?” – Rachel Gattman, The Atlantic The pandemic has shown that it is always better to have more protection “While it is clear that the FDA is careful, I like their decision. Let ‘s face it: Every time we thought the shore was clear to Covid, we were wrong. “And every time we thought we had collective immunity to the virus – from a previous illness or from vaccines – we were wrong.” – Kent Sepkowitz, CNN The FDA was smart to make the second amplifiers a matter of personal choice “Those who have been vaccinated and strengthened may not choose an extra souvenir at this time, as they could choose not to wear a mask or have regular tests. … For the elderly and the medically weak who would end up in the hospital with any respiratory infection, I understand the rationale for choosing the extra shot. “They want to do everything they can to avoid infection with Covid-19.” – Leana Wen, Washington Post
Skeptics
We need better vaccines, not more doses than we already have “It has become clear that our current vaccines will not end the pandemic. But that’s no reason to give up hope. a vaccination campaign with better vaccines could still. ” – Fay Flam, Bloomberg The second amplifiers seem to make only a small difference “A fourth dose of mRNA vaccine for the average, healthy American can reduce the incidence of mild infections for weeks to months, but would have little additional impact on preventing serious illness and death.” – John P. Moore and Luciana L. Borio, Stat The goal should be to prevent serious infections and deaths, the initial doses already do “Protection against vaccine-induced infection is short-lived and is not greatly enhanced by additional vaccines. However, the initial two-dose regimen is sufficient to provide most patients with excellent protection against serious disease. – Philip Krause and Luciana Borio, Wall Street Journal It does not make sense to give people support when the incidence is relatively low “COVID vaccines are safe and effective and have undoubtedly saved millions of lives so far. “I think amplifiers are important and will continue to help save lives – but timing matters.” – Eddy Bresnitz, Philadelphia Inquirer The talk of souvenirs is irrelevant to so many people still unvaccinated “The most important thing we can do as individuals right now is, No. 1, to vaccinate the unvaccinated. There are so many people who have not started their turn for any reason. … The solution to this pandemic is to vaccinate as many people as possible. It’s still the solution to take us to the other side. ” – Sabrina Assoumou, infectious disease specialist, at the Boston Globe Vaccine fatigue is a real concern “What is the risk of frequent aid? There do not appear to be any immunological risks / health risks and opportunity costs. But there are psychological risks (eg vaccine fatigue & skepticism). “We have to ask the Americans to roll up their sleeves when it matters most.” – Céline Gounder, epidemiologist Is there an issue you would like to see covered in “The 360”? Send your suggestions to [email protected] Photo Illustration: Yahoo News? photos: Justin Sullivan / Getty Images
